GERCOR-GONO DEWI
What it tests: Watch-and-wait strategy with dostarlimab in localized dMMR/MSI-H gastroesophageal adenocarcinoma (first interim analysis)
The week in oncology, in your inbox
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.